Welcome to Jackson28 Jan 2023 21:40
As this US share is sp****ly known here, and even less posted on, thought I'd write a quick synopsis of Jackson (JXN), of which I'm a big fan.
I'm a holder, having previously held (UK) PRU shares and received them in a spin off, and there must be many many PRU holders who have these, (who sporadically mention on the PRU board), but I have gone on to buy more on a couple of occasions.
I'm generally a yield and/or value investor, and see growth stocks generally as an illusionary continual promise of jam tommorow. I prefer a little jam every day. Unusually I see JXN by virtue of it's business, of being undervalued/underfollowed as potentially a high yielder that could also see considerable SP growth.
In a nutshell, it's a pension/annuity provider, taking fees along the way for providing a promissory level of income/payout. In some regards it shares some similarities to PNX, albeit they are more managing live policies/plans rather than running down/realising them.
Plus sides - their ongoing fee income is substantial, this year alone being over half their mkt cap.
Continual market with increasing life expectancy, growing aged population.
Well respected, award winning in their market, a market leader in a disparate market (Lincoln National is a comparator/competitor).
Current yield 5% plus with buybacks in operation.
Downsides - little stand alone reporting/accounts due to recent spin out suggests no history/longevity of success/profitability, despite being long established/a household name.
Consequently little analyst/financial coverage/awareness compounded by, in US terms, JXN is a minnow not worthy of coverage/investment.
JXN extensively deploys options to underpin it's obligations, which in accounting terms are reported in quick one time terms, often resulting in very large headline losses, that frighten the mkts, seemingly being detached from the longevity of fees, policy success they are underpinning.
Being in US terms a minnow it is subject to a large short interest that would ordinarily ring alarm bells here in the UK, having recently been 12% but sharply reduced recently to around 4%, and this can cause sharp gyrations 10/15% in a week, so not for the faint hearted - I've been down AND up 20% in 6 months.
The company has non obligated cash at hand equal to 15% of it's market cap, a p/e of less than 1 and yields 5% in a market, which has no end.
I strongly believe that within 3 years the annual cash throw off will constitute a 10% yielder, for the patient.
Hope this helps someone, engenders some discussion with PRU holders and others, away from, distinct from the PRU board.